PRUDENTIAL FINANCIAL INC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 118 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$5,426,000
-8.1%
102,708
+6.6%
0.01%
-9.1%
Q2 2020$5,904,000
+20.2%
96,342
+11.0%
0.01%0.0%
Q1 2020$4,910,000
-16.0%
86,802
-15.4%
0.01%
+22.2%
Q4 2019$5,842,000
+13.8%
102,610
+7.0%
0.01%
+12.5%
Q3 2019$5,134,000
+30.1%
95,916
+45.2%
0.01%
+33.3%
Q2 2019$3,945,000
-9.4%
66,067
-5.4%
0.01%
-14.3%
Q1 2019$4,353,000
+0.5%
69,837
-2.3%
0.01%
-12.5%
Q4 2018$4,332,000
+0.8%
71,498
-2.7%
0.01%
+33.3%
Q3 2018$4,297,000
+17.3%
73,468
-10.0%
0.01%
+20.0%
Q2 2018$3,663,000
+12.8%
81,644
+11.5%
0.01%0.0%
Q1 2018$3,246,000
-0.4%
73,192
-2.7%
0.01%
+25.0%
Q4 2017$3,258,000
+4.0%
75,188
+11.6%
0.00%
-20.0%
Q3 2017$3,134,000
-3.7%
67,367
+2.5%
0.01%0.0%
Q2 2017$3,255,000
-9.2%
65,747
+0.5%
0.01%
-16.7%
Q1 2017$3,585,000
-2.4%
65,419
-0.9%
0.01%0.0%
Q4 2016$3,675,000
+34.3%
65,989
+10.1%
0.01%
+20.0%
Q3 2016$2,737,000
+23.9%
59,940
+8.4%
0.01%
+25.0%
Q2 2016$2,209,000
+120.5%
55,300
+92.2%
0.00%
+100.0%
Q1 2016$1,002,000
-6.0%
28,766
+16.0%
0.00%0.0%
Q4 2015$1,066,000
-21.3%
24,800
-20.3%
0.00%
-33.3%
Q3 2015$1,354,000
+170.3%
31,100
+220.6%
0.00%
+200.0%
Q2 2015$501,0009,7000.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders